Determinants of Dual-Task Training Effect Size in Parkinson Disease: Who Will Benefit Most?

Related Articles

Determinants of Dual-Task Training Effect Size in Parkinson Disease: Who Will Benefit Most?

J Neurol Phys Ther. 2019 Jan;43(1):3-11

Authors: Strouwen C, Molenaar EALM, Münks L, Broeder S, Ginis P, Bloem BR, Nieuwboer A, Heremans E

Abstract
BACKGROUND AND PURPOSE: Dual-task interventions show positive effects in people with Parkinson disease (PD), but it remains unclear which factors determine the size of these benefits. As a secondary analysis of the DUALITY trial, the aim of this study was to assess the determinants of the effect size after 2 types of dual-task practice.
METHODS: We randomly allocated 121 participants with PD to receive either integrated or consecutive dual-task training. Dual-task walking performance was assessed during (i) a backward digit span task (digit), (ii) an auditory Stroop task (Stroop), and (iii) a functional mobile phone task. Baseline descriptive, motor, and cognitive variables were correlated with the change in dual-task gait velocity after the intervention. Factors correlated with the change in dual-task gait velocity postintervention (P < 0.20) were entered into a stepwise forward multiple linear regression model.
RESULTS: Lower dual-task gait velocity and higher cognitive capacity (Scales for Outcomes in Parkinson's Disease-Cognition [ScopaCog]) at baseline were related to larger improvements in dual-task gait velocity after both integrated and consecutive dual-task training for all 3 tasks (β[gait] = -0.45, β[ScopaCog] = 0.34, R = 0.23, P < 0.001, for digit; β[gait] = -0.52, β[ScopaCog] = 0.29, R = 0.26, P < 0.001, for Stroop; and β[gait] = -0.40, β[ScopaCog] = 0.30, R = 0.18, P < 0.001, for mobile phone task).
DISCUSSION AND CONCLUSIONS: Participants with PD who showed a slow dual-task gait velocity and good cognitive functioning at baseline benefited most from the dual-task training, irrespective of the type of training and type of dual-task outcome.Video Abstract available for more insights from the authors (see Video, Supplemental Digital Content 1, available at: https://ift.tt/2EirtJe).

PMID: 30531381 [PubMed - in process]

from PubMed via alexandrossfakianakis on Inoreader https://ift.tt/2EufpFJ